Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
2.51    0.00 (0.00%)
Bid:
0.00
Ask:
14.00
Spread: 11.60 (483.333%)
Market Cap: £4.58m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

Material Development and Supply Agreement

8 Feb 2018 07:00

RNS Number : 2474E
Nanoco Group PLC
08 February 2018
 

This announcement contains inside information as defined in EU Regulation No. 596/2014 and is in accordance with the Company's obligations under Article 17 of that Regulation.

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

Material Development and Supply Agreement

 

New partnership includes infrastructure investment, development, milestones and commercial supply agreement

 

Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and nanomaterials, announces that it has signed a Material Development and Supply Agreement with a large, undisclosed US listed corporation (the "Partner").

 

Under this agreement, Nanoco will scale-up and mass produce novel nano-particles for advanced electronic devices and supply them from its state-of-the-art production facility in Runcorn, UK. In preparation for the quantity of materials needed for these markets, the Partner will fund the capital expenditure required to expand Nanoco's Runcorn facility. The commercial terms of the agreement include payments for success based milestones, and commercial supply of materials, both of which will strengthen Nanoco's balance sheet. Based on the current timelines, commercial supply is anticipated to begin early 2019.

 

Michael Edelman, Chief Executive of Nanoco, said:

 

"This transaction not only exemplifies the potential of our technology, but also the recognition that Nanoco can continue to pursue broad partnerships in diverse markets.

 

Our deep expertise in the development and mass production of highly differentiated nanoparticles has enabled us to create partnerships, and future revenue streams, with partners around the globe. We are very pleased to announce today's agreement, and we look forward to updating you on our progress."

 

For further information, please contact:

 

Nanoco Group PLC Tel: +44 7788 897 357

Caroline Watson, Investor Relations Manager

Cwatson@nanocotechnologies.com

  

MHP Communications Tel: +44 (0) 20 3128 8570

Reg Hoare / Andrew Leach / Giles Robinson / Pete Lambie

nanoco@mhpc.com

 

The person responsible for arranging for the release of this announcement on behalf of the Company is David Blain, Chief Financial Officer.

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, Nanoco has non-exclusive manufacturing and marketing licensing agreements with The Dow Chemical Company, Merck KGaA and Taiwan's Wah Hong Industrial Corporation. Nanoco also has a strategy of direct sales in display and in its other target markets, including lighting.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTZMGGZRNZGRZM
Date   Source Headline
18th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 20247:00 amRNSConclusions of Strategic Review
1st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 202410:51 amRNSHolding(s) in Company
24th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20241:08 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
2nd Sep 20241:34 pmRNSHolding(s) in Company
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Aug 20247:00 amRNSCommercial Update
29th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20247:21 amRNSTransaction in Own Shares and Total Voting Rights
5th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jul 20249:16 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20247:00 amRNSBoard and Management Change
25th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Jul 20242:14 pmRNSTransaction in Own Shares and Total Voting Rights
18th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.